Changeflow GovPing Pharma & Drug Safety EPO Patent Application: Protein Design Systems ...
Routine Notice Added Final

EPO Patent Application: Protein Design Systems and Methods

Favicon for changeflow.com ChangeBridge: EPO Bulletin - Biotech (C12N)
Published March 18th, 2026
Detected March 24th, 2026
Email

Summary

The European Patent Office has published patent application EP2026030717A1 concerning protein design systems and methods. The application was published on March 18, 2026, and includes classifications related to biotechnology and artificial intelligence. The inventors have not yet been designated.

What changed

This document is a publication of a European patent application (EP2026030717A1) for "Protein Design Systems and Methods." The application was published by the European Patent Office (EPO) on March 18, 2026. It includes IPC classifications related to protein chemistry, machine learning, and bioinformatics, indicating a focus on advanced computational methods for biological design.

As this is a patent application publication, it does not impose direct compliance obligations on regulated entities. However, companies operating in the biotechnology and pharmaceutical sectors should be aware of this publication as it may indicate new technological developments or potential intellectual property claims in the area of protein design. The application is designated for numerous European states.

Source document (simplified)

← EPO Patent Bulletin

SYSTEMS AND METHODS FOR PROTEIN DESIGN

Publication EP2026030717A1 Kind: A1 Mar 18, 2026

Inventors

The designation of the inventor has not yet been filed

IPC Classifications

C07K 16/00 20060101AFI20260208BHEP G06N 3/02 20060101ALI20260208BHEP G16B 15/20 20190101ALI20260208BHEP C12N 15/10 20060101ALI20260208BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Named provisions

SYSTEMS AND METHODS FOR PROTEIN DESIGN

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
EPO
Published
March 18th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
EP2026030717A1

Who this affects

Applies to
Manufacturers Technology companies
Industry sector
3254 Pharmaceutical Manufacturing 5112 Software & Technology
Activity scope
Drug Discovery Biotechnology Research
Geographic scope
European Union EU

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Biotechnology Artificial Intelligence

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: EPO Bulletin - Biotech (C12N) publishes new changes.

Free. Unsubscribe anytime.